| RS483352880 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352881 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352882 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS483352883 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352884 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352885 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352886 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352887 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352888 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS483352889 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352890 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS483352891 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS483352893 |
NPC2
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C2 |
| RS483352894 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS483352895 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS483352896 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS483352897 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS483352898 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS483352899 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS483352900 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS483352901 |
STX11
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 4, Familial hemophagocytic lymphohistiocytosis 4 |
| RS483352902 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS483352903 |
SERPINA7
|
Health Risk |
association |
Thyroxine-binding globulin quantitative trait locus, Thyroxine-binding globulin quantitative trait locus |
| RS483352904 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS483352905 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS483352906 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS483352907 |
NEK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 3, NEK1-related disorder |
| RS483352908 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS483352909 |
POLE
|
Health Risk |
Pathogenic |
Colorectal cancer, susceptibility to |
| RS483352910 |
SLC25A1
|
Health Risk |
Likely pathogenic |
D, L-2-hydroxyglutaric aciduria |
| RS483352911 |
SLC25A1
|
Health Risk |
Pathogenic/Likely pathogenic |
2-hydroxyglutaric aciduria, D |
| RS483352913 |
ADAM10
|
Health Risk |
Pathogenic |
Reticulate acropigmentation of Kitamura, Reticulate acropigmentation of Kitamura |
| RS483352914 |
ADAM10
|
Health Risk |
Pathogenic |
Reticulate acropigmentation of Kitamura, Reticulate acropigmentation of Kitamura |
| RS483352915 |
ADAM10
|
Health Risk |
Pathogenic |
Reticulate acropigmentation of Kitamura, Reticulate acropigmentation of Kitamura |
| RS483352916 |
ADAM10
|
Health Risk |
Pathogenic |
Reticulate acropigmentation of Kitamura, Reticulate acropigmentation of Kitamura |
| RS483352917 |
DCHS1
|
Health Risk |
Pathogenic |
Van Maldergem syndrome 1, Van Maldergem syndrome 1 |
| RS483352918 |
DCHS1
|
Health Risk |
Pathogenic |
Van Maldergem syndrome 1, Van Maldergem syndrome 1 |
| RS483352919 |
DCHS1
|
Health Risk |
Pathogenic |
Van Maldergem syndrome 1, Van Maldergem syndrome 1 |
| RS483352920 |
SCN11A
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 7, Hereditary sensory and autonomic neuropathy type 7 |
| RS483352921 |
SCN11A
|
Health Risk |
Likely pathogenic |
Familial episodic pain syndrome with predominantly lower limb involvement, Congenital sensory neuropathy with selective loss of small myelinated fibers |
| RS483352922 |
TBC1D7
|
Health Risk |
Pathogenic |
Macrocephaly/megalencephaly syndrome, autosomal recessive |
| RS483352923 |
REEP2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 72, Hereditary spastic paraplegia 72 |
| RS483352924 |
REEP2
|
Health Risk |
Pathogenic |
Spastic paraplegia 72b, autosomal recessive |
| RS483352925 |
REEP2
|
Health Risk |
Pathogenic |
Spastic paraplegia 72b, autosomal recessive |
| RS483352926 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS483352927 |
CD3G
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS483352928 |
CD3E
|
Health Risk |
Likely pathogenic |
Immunodeficiency 18, Immunodeficiency 18 |
| RS483352929 |
CD3E
|
Health Risk |
Pathogenic |
Immunodeficiency 18, severe combined immunodeficiency variant |
| RS483352930 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS483352970 |
CDKN1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS483352971 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS483352987 |
CDKN1C
|
Health Risk |
Pathogenic |
— |
| RS483352988 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS483352989 |
CDKN1C
|
Health Risk |
Pathogenic |
IMAGe syndrome, IMAGe syndrome |
| RS483352991 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS483352993 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS483352997 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS483353013 |
LRP1
|
Health Risk |
Pathogenic |
Atrophoderma vermiculatum, Keratosis pilaris |
| RS483353016 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Cardiovascular phenotype |
| RS483353022 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353023 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353024 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Relapsing remitting multiple sclerosis, Relapsing remitting multiple sclerosis |
| RS483353028 |
HNRNPA1
|
Health Risk |
Pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353029 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353030 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353031 |
HNRNPA1
|
Health Risk |
Pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353032 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353033 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353034 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353035 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353036 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353038 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353039 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Chronic progressive multiple sclerosis, Chronic progressive multiple sclerosis |
| RS483353044 |
HNF1A
|
Health Risk |
Pathogenic |
Type 1 diabetes mellitus 20, Type 1 diabetes mellitus 20 |
| RS483353045 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Myasthenic syndrome, congenital |
| RS483353046 |
CHRNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Slow-Channel Congenital Myasthenia Syndrome, Slow-Channel Congenital Myasthenia Syndrome |
| RS483353047 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS483353048 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS483353049 |
OTOF
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS483353050 |
OTOF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Nonsyndromic genetic hearing loss |
| RS483353054 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS483353055 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS483353056 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS483353057 |
SOX10
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 4C, Waardenburg syndrome type 4C |
| RS483353058 |
SOX10
|
Health Risk |
Likely pathogenic |
PCWH syndrome, PCWH syndrome |
| RS483353059 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS483353063 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS483353064 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS483353065 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS483353066 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS483353067 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Primrose syndrome, Primrose syndrome |
| RS483353068 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS483353069 |
ZBTB20
|
Health Risk |
Pathogenic/Likely pathogenic |
Primrose syndrome, Inborn genetic diseases |
| RS483353070 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS483353071 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS483353072 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS483353073 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS483353074 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS483353077 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast neoplasm |
| RS483353078 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |